"Washington state has accumulated a critical mass of expertise in crucial areas necessary for the successful identification and development of vaccines. The creation of WAVA provides the catalyst to allow each member to create new programs that build upon the substantial existing successes," said King Holmes, M.D., Ph.D., chair of the UW Department of Global Health.
The portfolio of vaccine projects for WAVA covers major infectious diseases that await the development of effective and affordable vaccines. These include HIV, hepatitis C, influenza, diarrheal diseases (especially of infants and children), pneumonia of the elderly, sexually transmitted infections (such as genital herpes, syphilis, and chlamydia), and the pandemic infections of tuberculosis and malaria.
"The worldwide recognition of the potential for vaccines -- increased use of existing, improved and new -- creates the opportunity for the state of Washington to contribute to an unprecedented reduction of the human and financial costs of some of our greatest health challenges," said Chris Elias, M.D., M.P.H., president and CEO of PATH.
At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit fhcrc.org.
About the Life Sciences Discovery Fund
The Life Sciences Discovery F
|SOURCE Fred Hutchinson Cancer Research Center|
Copyright©2008 PR Newswire.
All rights reserved